Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns reut.rs/49Bc0Si https://reut.rs/49Bc0Si
2026-06-02T02:50:11.471Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.